Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Baxter
Cipla
Express Scripts
Cantor Fitzgerald
Accenture

Generated: May 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,076,494

« Back to Dashboard

Which drugs does patent 10,076,494 protect, and when does it expire?

Patent 10,076,494 protects OMEPRAZOLE and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 10,076,494
Title:Stable orally disintegrating pharmaceutical compositions
Abstract: Described herein are stable orally disintegrating tablets containing a proton pump inhibitor, methods for making the same, and methods for treating subjects in need thereof. In particular, the orally disintegrating tablets are composed of a plurality of coated units admixed with a disintegrant that demonstrate decreased friability and increased hardness.
Inventor(s): Pevzner; Victor (Hadera, IL), Moses-Heller; Sheera (Atlit, IL)
Assignee: DEXCEL PHARMA TECHNOLOGIES LTD. (Or-Akiva, IL)
Application Number:15/372,917
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 10,076,494
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 10,076,494

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Dexcel Pharma OMEPRAZOLE omeprazole TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 209400-001 Jul 5, 2017 OTC Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Merck
Fuji
Colorcon
AstraZeneca
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.